Cargando…
Dose Adjustments of Hydrocortisone and L-thyroxine in Hypopituitarism Associated with Cholestasis
A patient with congenital hypopituitarism associated with cholestasis is reported here. Large doses of fat-soluble hormones (hydrocortisone (20 mg/m(2)/day) and L-thyroxine (14 μg/kg/day)) were needed to resolve hypoglycemia and hypothyroidism during cholestasis. The doses could be reduced to 10 mg/...
Autores principales: | Higuchi, Asako, Hasegawa, Yukihiro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japanese Society for Pediatric Endocrinology
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4004839/ https://www.ncbi.nlm.nih.gov/pubmed/24790327 http://dx.doi.org/10.1297/cpe.15.93 |
Ejemplares similares
-
An association with hypopituitarism and 9q subtelomere deletion syndrome
por: Higuchi, Shinji, et al.
Publicado: (2018) -
Stress Doses of Glucocorticoids Cannot Prevent Progression of All Adrenal
Crises
por: Aso, Keiko, et al.
Publicado: (2009) -
Basal Serum Thyroxine Level should Guide Initial Thyroxine Replacement Dose in Neonates with Congenital Hypothyroidism
por: Günbey, Ceren, et al.
Publicado: (2021) -
Hypopituitarism Associated with Glycosuria
por: Gibson, Henry J. C.
Publicado: (1924) -
Validity of Six Month L-Thyroxine Dose for Differentiation of Transient or Permanent Congenital Hypothyroidism
por: Asena, Muhammet, et al.
Publicado: (2020)